These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

949 related items for PubMed ID: 18430493

  • 1. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
    Mutwiri G, Benjamin P, Soita H, Babiuk LA.
    Vaccine; 2008 May 23; 26(22):2680-8. PubMed ID: 18430493
    [Abstract] [Full Text] [Related]

  • 2. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
    Bian G, Cheng Y, Wang Z, Hu Y, Zhang X, Wu M, Chen Z, Shi B, Sun S, Shen Y, Chen EJ, Yao X, Wen Y, Yuan Z.
    Vaccine; 2009 Dec 10; 28(1):187-94. PubMed ID: 19789093
    [Abstract] [Full Text] [Related]

  • 3. CpG oligonucleotide, host defense peptide and polyphosphazene act synergistically, inducing long-lasting, balanced immune responses in cattle.
    Kovacs-Nolan J, Mapletoft JW, Latimer L, Babiuk LA, Hurk Sv.
    Vaccine; 2009 Mar 23; 27(14):2048-54. PubMed ID: 19428829
    [Abstract] [Full Text] [Related]

  • 4. Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen.
    Song ES, Park SA, Kim SH, Cho YJ, Ahn BY, Ahn BC, Lee NG.
    FEMS Immunol Med Microbiol; 2007 Dec 23; 51(3):496-504. PubMed ID: 17877731
    [Abstract] [Full Text] [Related]

  • 5. CpG ODN enhances immunization effects of hepatitis B vaccine in aged mice.
    Qin W, Jiang J, Chen Q, Yang N, Wang Y, Wei X, Ou R.
    Cell Mol Immunol; 2004 Apr 23; 1(2):148-52. PubMed ID: 16212903
    [Abstract] [Full Text] [Related]

  • 6. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice.
    McCluskie MJ, Davis HL.
    J Immunol; 1998 Nov 01; 161(9):4463-6. PubMed ID: 9794366
    [Abstract] [Full Text] [Related]

  • 7. Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens.
    Mutwiri G, Benjamin P, Soita H, Townsend H, Yost R, Roberts B, Andrianov AK, Babiuk LA.
    Vaccine; 2007 Jan 26; 25(7):1204-13. PubMed ID: 17140708
    [Abstract] [Full Text] [Related]

  • 8. A new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAg.
    Khajuria A, Gupta A, Malik F, Singh S, Singh J, Gupta BD, Suri KA, Suden P, Srinivas VK, Ella K, Qazi GN.
    Vaccine; 2007 Jun 06; 25(23):4586-94. PubMed ID: 17498851
    [Abstract] [Full Text] [Related]

  • 9. [Impact of different adjuvants on immunogenicity of the HBV particle vaccine containing the S + preS1 fusion antigen in Balb/C mice].
    Chen H, Deng Y, Tan W, Wang W, Yin X, Guan J, Wang W, Ruan L.
    Sheng Wu Gong Cheng Xue Bao; 2010 Jan 06; 26(1):74-8. PubMed ID: 20353095
    [Abstract] [Full Text] [Related]

  • 10. Immunomodulation of Japanese encephalitis vaccine through CpG oligodeoxynucleotides in mice.
    Sidhapuriwala JN, Sivalingam SP, Lu J, Moochhala SM.
    Scand J Immunol; 2006 Oct 06; 64(4):370-5. PubMed ID: 16970676
    [Abstract] [Full Text] [Related]

  • 11. Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis.
    Garlapati S, Eng NF, Kiros TG, Kindrachuk J, Mutwiri GK, Hancock RE, Halperin SA, Potter AA, Babiuk LA, Gerdts V.
    Vaccine; 2011 Sep 02; 29(38):6540-8. PubMed ID: 21771625
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of immune responses to hepatitis B vaccine in immunodepressed mice by CpG oligodeoxynucleotide.
    Qin WB, Jiang JW, Yang N, Chen QE, Wang YF, Wei XC, Ou RQ.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov 02; 20(6):647-50. PubMed ID: 15555425
    [Abstract] [Full Text] [Related]

  • 13. The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody- and cell-mediated immune responses in mice.
    Kovacs-Nolan J, Latimer L, Landi A, Jenssen H, Hancock RE, Babiuk LA, van Drunen Littel-van den Hurk S.
    Vaccine; 2009 Mar 23; 27(14):2055-64. PubMed ID: 19428830
    [Abstract] [Full Text] [Related]

  • 14. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
    Wild J, Grusby MJ, Schirmbeck R, Reimann J.
    J Immunol; 1999 Aug 15; 163(4):1880-7. PubMed ID: 10438922
    [Abstract] [Full Text] [Related]

  • 15. Formulation with CpG oligodeoxynucleotides prevents induction of pulmonary immunopathology following priming with formalin-inactivated or commercial killed bovine respiratory syncytial virus vaccine.
    Oumouna M, Mapletoft JW, Karvonen BC, Babiuk LA, van Drunen Littel-van den Hurk S.
    J Virol; 2005 Feb 15; 79(4):2024-32. PubMed ID: 15681404
    [Abstract] [Full Text] [Related]

  • 16. CpG-ODN combined with Neospora caninum lysate, but not with excreted-secreted antigen, enhances protection against infection in mice.
    Ribeiro DP, Freitas MM, Cardoso MR, Pajuaba AC, Silva NM, Mineo TW, Silva JS, Mineo JR, Silva DA.
    Vaccine; 2009 Apr 28; 27(19):2570-9. PubMed ID: 19428863
    [Abstract] [Full Text] [Related]

  • 17. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.
    Borges O, Silva M, de Sousa A, Borchard G, Junginger HE, Cordeiro-da-Silva A.
    Int Immunopharmacol; 2008 Dec 20; 8(13-14):1773-80. PubMed ID: 18801462
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of poly[di(sodium carboxylatophenoxy)phosphazene] (PCPP) as mucosal adjuvant to induce protective immunity against respiratory pathogens.
    Shim DH, Ko HJ, Volker G, Potter AA, Mutwiri G, Babiuk LA, Kweon MN.
    Vaccine; 2010 Mar 08; 28(11):2311-7. PubMed ID: 20060944
    [Abstract] [Full Text] [Related]

  • 19. Adjuvant activities of immune response modifier R-848: comparison with CpG ODN.
    Vasilakos JP, Smith RM, Gibson SJ, Lindh JM, Pederson LK, Reiter MJ, Smith MH, Tomai MA.
    Cell Immunol; 2000 Aug 25; 204(1):64-74. PubMed ID: 11006019
    [Abstract] [Full Text] [Related]

  • 20. Oligodeoxynucleotides containing synthetic immunostimulatory motifs augment potent Th1 immune responses to HBsAg in mice.
    Li Y, Kandimalla ER, Yu D, Agrawal S.
    Int Immunopharmacol; 2005 Jun 25; 5(6):981-91. PubMed ID: 15829414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.